The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

Simple item page
dc.contributor.authorVogel, Birgit
dc.contributor.authorAcevedo, Monica
dc.contributor.authorAppelman, Yolande
dc.contributor.authorMerz, C. Noel Bairey
dc.contributor.authorChieffo, Alaide
dc.contributor.authorFigtree, Gemma A.
dc.contributor.authorGuerrero, Mayra
dc.contributor.authorKunadian, Vijay
dc.contributor.authorLam, Carolyn S. P.
dc.contributor.authorMaas, Angela H. E. M.
dc.contributor.authorMihailidou, Anastasia S.
dc.contributor.authorOlszanecka, Agnieszka
dc.contributor.authorPoole, Jeanne E.
dc.contributor.authorSaldarriaga, Clara
dc.contributor.authorSaw, Jacqueline
dc.contributor.authorZuhlke, Liesl
dc.contributor.authorMehran, Roxana
dc.date.accessioned2025-05-01T10:30:23Z
dc.date.available2025-05-01T10:30:23Z
dc.date.issued2021
dc.description.abstractCardiovascular disease is the leading cause of death in women. Decades of grassroots campaigns have helped to raise awareness about the impact of cardiovascular disease in women, and positive changes affecting women and their health have gained momentum. Despite these efforts, there has been stagnation in the overall reduction of cardiovascular disease burden for women in the past decade. Cardiovascular disease in women remains understudied, under-recognised, underdiagnosed, and undertreated. This Commission summarises existing evidence and identifies knowledge gaps in research, prevention, treatment, and access to care for women. Recommendations from an international team of experts and leaders in the field have been generated with a clear focus to reduce the global burden of cardiovascular disease in women by 2030. This Commission represents the first effort of its kind to connect stakeholders, to ignite global awareness of sex-related and gender-related disparities in cardiovascular disease, and to provide a springboard for future research.
dc.description.funderAbbott Vascular
dc.description.funderAbiomed
dc.description.funderAmgen
dc.description.funderAstraZeneca
dc.description.funderBristol Myers Squibb
dc.description.funderCSL Behring
dc.description.funderJanssen
dc.description.funderMedtronic
dc.description.funderOrbus Neich
dc.description.funderPhilips
dc.description.funderSanofi
dc.format.extent54 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1016/S0140-6736(21)00684-X
dc.identifier.eissn1474-547X
dc.identifier.issn0140-6736
dc.identifier.pubmedidMEDLINE:34010613
dc.identifier.scieloidS0718-69242020000300109
dc.identifier.scopusidSCOPUS_ID:65649135122
dc.identifier.urihttps://doi.org/10.1016/S0140-6736(21)00684-X
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/103629
dc.identifier.wosidWOS:000663124100026
dc.information.autorucEscuela de Medicina; Acevedo Blanco Monica Andrea; S/I; 81173
dc.issue.numero10292
dc.language.isoen
dc.nota.accesoSin adjunto
dc.pagina.final2438
dc.pagina.inicio2385
dc.relation.ispartof16th International Vasculitis & ANCA Workshop
dc.revistaLANCET
dc.rightsregistro bibliográfico
dc.subjectACUTE MYOCARDIAL-INFARCTION
dc.subjectCORONARY-ARTERY DISSECTION
dc.subjectRHEUMATIC HEART-DISEASE
dc.subjectSUDDEN CARDIAC DEATH
dc.subjectST-SEGMENT-ELEVATION
dc.subjectMECHANICAL CIRCULATORY SUPPORT
dc.subjectINTIMATE PARTNER VIOLENCE
dc.subjectSEX-BASED DIFFERENCES
dc.subjectIMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
dc.subjectHEALTHY POSTMENOPAUSAL WOMEN
dc.subject.ddc400
dc.subject.deweyLenguases_ES
dc.subject.ods11 Sustainable cities and communities
dc.subject.odspa11 Ciudades y comunidades sostenibles
dc.titleThe Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
dc.typeartículo
dc.volumen397
sipa.codpersvinculados81173
sipa.indexWOS
sipa.trazabilidadCarga WOS-SCOPUS;01-05-2025
Files
Collections
Artículos de revistas